RecruitingNCT05332756

Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)

Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives

Sponsor

Beijing Tiantan Hospital

Enrollment

400 participants

Start Date

May 1, 2022

Study Type

OBSERVATIONAL

Conditions

Moyamoya Disease

Summary

The purpose of this study is to investigate the long-term outcomes of conservative management in patients with moyamoya disease and their first-degree relatives, and provide potential pathogenesis of moyamoya disease.

Eligibility

Min Age: 2 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Conservative management for people with moyamoya disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 2 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERConservative management

Patients and their first-degree relatives will be medically treated with antiplatelets, antiepileptics, antihypertensives and vasodilators depending on the presentation.